Our Focus

"To be stewards of integrity, thoroughness and interpersonal flexibility in every transaction in order to mitigate chronic diseases.”
- Dr. Brian Curry, CEO of PhysioGenix

Healthcare trends. 

The United States has witnessed a dramatic change in the disease profile that contributes to morbidity and mortality. “Chronic disease” is defined by the CDC as non-communicable illnesses that are prolonged in duration, do not resolve spontaneously, and are rarely cured completely, such as heart disease, cancer, and diabetes, which are the most prevalent and costly health issues. Every year chronic diseases cause 7 out of 10 deaths in the United States. This corresponds to 133 million Americans or nearly 1 in 2 adults living with a chronic disease. Chronic diseases also place a heavy burden on the United States healthcare system, representing over 75% of all healthcare costs. 
A world-leader in complex chronic disease research services and solutions. Our goal is to be the world-leader in research services and solutions for organizations developing therapeutics and medical devices for complex chronic diseases. Through our in-house capabilities and collaborative partnerships, we seek to deliver the most comprehensive suite of solutions in the field of complex chronic diseases

Our services. 

We work as an integral part of our client’s drug and medical device development process. Our preclinical in vivo services include efficacy, pharmacodynamics, pharmacokinetics, and behavioral analysis. We also offer bioanalytical, laboratory, and surgical services. We focus on complex chronic diseasesdiabetes, metabolic disorders, cardiovascular disease, and neurological disorders.